$45.36
2.86% yesterday
NYSE, Nov 20, 10:00 pm CET
ISIN
US4333131039
Symbol
HNGE

Hinge Health Target price 2025 - Analyst rating & recommendation

Hinge Health Classifications & Recommendation:

Buy
90%
Hold
10%

Hinge Health Price Target

Target Price $65.79
Price $45.36
Potential
Number of Estimates 16
16 Analysts have issued a price target Hinge Health 2026 . The average Hinge Health target price is $65.79. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 21 analysts: 19 Analysts recommend Hinge Health to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Hinge Health stock has an average upside potential 2026 of . Most analysts recommend the Hinge Health stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2031

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Million $ 390.40 561.52
33.37% 43.83%
EBITDA Margin -4.73% 14.63%
88.90% 409.07%
Net Margin -3.06% 8.28%
91.73% 370.96%

17 Analysts have issued a sales forecast Hinge Health 2025 . The average Hinge Health sales estimate is

$562m
Unlock
. This is
14.05% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$583m 10.79%
Unlock
, the lowest is
$538m 17.68%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $390m 33.37%
2025
$562m 43.83%
Unlock
2026
$672m 19.69%
Unlock
2027
$787m 17.13%
Unlock
2028
$882m 12.07%
Unlock
2029
$1.0b 15.49%
Unlock
2030
$1.2b 14.33%
Unlock
2031
$1.3b 13.30%
Unlock

13 Analysts have issued an Hinge Health EBITDA forecast 2025. The average Hinge Health EBITDA estimate is

$82.1m
Unlock
. This is
113.87% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$106m 117.83%
Unlock
, the lowest is
$24.1m 104.06%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-18.5m 85.20%
2025
$82.1m 544.53%
Unlock
2026
$112m 35.79%
Unlock
2027
$146m 31.14%
Unlock
2028
$214m 46.00%
Unlock
2029
$275m 28.55%
Unlock
2030
$334m 21.77%
Unlock
2031
$392m 17.17%
Unlock

EBITDA Margin

2024 -4.73% 88.90%
2025
14.63% 409.07%
Unlock
2026
16.60% 13.47%
Unlock
2027
18.58% 11.93%
Unlock
2028
24.21% 30.30%
Unlock
2029
26.95% 11.32%
Unlock
2030
28.70% 6.49%
Unlock
2031
29.68% 3.41%
Unlock

17 Hinge Health Analysts have issued a net profit forecast 2025. The average Hinge Health net profit estimate is

$46.5m
Unlock
. This is
106.89% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$128m 119.01%
Unlock
, the lowest is
$-497m 26.34%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-11.9m 88.97%
2025
$46.5m 489.69%
Unlock
2026
$91.3m 96.43%
Unlock
2027
$114m 24.86%
Unlock
2028
$159m 39.09%
Unlock
2029
$198m 24.62%
Unlock
2030
$234m 18.55%
Unlock
2031
$269m 14.62%
Unlock

Net Margin

2024 -3.06% 91.73%
2025
8.28% 370.96%
Unlock
2026
13.59% 64.13%
Unlock
2027
14.48% 6.55%
Unlock
2028
17.97% 24.10%
Unlock
2029
19.40% 7.96%
Unlock
2030
20.11% 3.66%
Unlock
2031
20.35% 1.19%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2031

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share $ -0.15 0.59
89.21% 493.33%
P/E 76.24
EV/Sales 5.57

17 Analysts have issued a Hinge Health forecast for earnings per share. The average Hinge Health EPS is

$0.59
Unlock
. This is
103.84% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$1.64 110.68%
Unlock
, the lowest is
$-6.36 58.57%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.15 89.21%
2025
$0.59 493.33%
Unlock
2026
$1.17 98.31%
Unlock
2027
$1.46 24.79%
Unlock
2028
$2.03 39.04%
Unlock
2029
$2.53 24.63%
Unlock
2030
$3.00 18.58%
Unlock
2031
$3.44 14.67%
Unlock

P/E ratio

Current
2025
76.24 2,680.03%
Unlock
2026
38.81 49.09%
Unlock
2027
31.08 19.92%
Unlock
2028
22.35 28.09%
Unlock
2029
17.93 19.78%
Unlock
2030
15.13 15.62%
Unlock
2031
13.20 12.76%
Unlock

Based on analysts' sales estimates for 2025, the Hinge Health stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.79
2025
5.57 16.38%
Unlock
2026
4.66 16.45%
Unlock
2027
3.98 14.63%
Unlock
2028
3.55 10.77%
Unlock
2029
3.07 13.41%
Unlock
2030
2.69 12.53%
Unlock
2031
2.37 11.74%
Unlock

P/S ratio

Current
2025
6.31 16.35%
Unlock
2026
5.27 16.45%
Unlock
2027
4.50 14.63%
Unlock
2028
4.02 10.77%
Unlock
2029
3.48 13.42%
Unlock
2030
3.04 12.53%
Unlock
2031
2.68 11.74%
Unlock

Current Hinge Health Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Canaccord Genuity
Locked
Locked
Locked Nov 05 2025
Barclays
Locked
Locked
Locked Nov 05 2025
Piper Sandler
Locked
Locked
Locked Nov 05 2025
Evercore ISI Group
Locked
Locked
Locked Oct 08 2025
Morgan Stanley
Locked
Locked
Locked Sep 23 2025
Stifel
Locked
Locked
Locked Sep 11 2025
Baird
Locked
Locked
Locked Sep 05 2025
Analyst Rating Date
Locked
Canaccord Genuity:
Locked
Locked
Nov 05 2025
Locked
Barclays:
Locked
Locked
Nov 05 2025
Locked
Piper Sandler:
Locked
Locked
Nov 05 2025
Locked
Evercore ISI Group:
Locked
Locked
Oct 08 2025
Locked
Morgan Stanley:
Locked
Locked
Sep 23 2025
Locked
Stifel:
Locked
Locked
Sep 11 2025
Locked
Baird:
Locked
Locked
Sep 05 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today